IBBQ vs. BBC
Compare and contrast key facts about Invesco Nasdaq Biotechnology ETF (IBBQ) and Virtus LifeSci Biotech Clinical Trials ETF (BBC).
IBBQ and BBC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IBBQ is a passively managed fund by Invesco that tracks the performance of the NASDAQ / Biotechnology. It was launched on Jun 11, 2021. BBC is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Clinical Trials Index. It was launched on Dec 16, 2014. Both IBBQ and BBC are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IBBQ or BBC.
Key characteristics
| IBBQ | BBC | |
|---|---|---|
| YTD Return | 1.65% | 11.49% |
| 1Y Return | 7.74% | 13.19% |
| Sharpe Ratio | 0.42 | 0.35 |
| Daily Std Dev | 16.66% | 32.71% |
| Max Drawdown | -37.94% | -72.73% |
| Current Drawdown | -17.27% | -55.81% |
Correlation
The correlation between IBBQ and BBC is 0.85, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
IBBQ vs. BBC - Performance Comparison
In the year-to-date period, IBBQ achieves a 1.65% return, which is significantly lower than BBC's 11.49% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IBBQ vs. BBC - Expense Ratio Comparison
IBBQ has a 0.00% expense ratio, which is lower than BBC's 0.79% expense ratio.
Risk-Adjusted Performance
IBBQ vs. BBC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotechnology ETF (IBBQ) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IBBQ vs. BBC - Dividend Comparison
IBBQ's dividend yield for the trailing twelve months is around 0.82%, more than BBC's 0.30% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBBQ Invesco Nasdaq Biotechnology ETF | 0.82% | 0.81% | 0.76% | 0.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 0.30% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.05% | 0.00% | 0.51% |
Drawdowns
IBBQ vs. BBC - Drawdown Comparison
The maximum IBBQ drawdown since its inception was -37.94%, smaller than the maximum BBC drawdown of -72.73%. Use the drawdown chart below to compare losses from any high point for IBBQ and BBC. For additional features, visit the drawdowns tool.
Volatility
IBBQ vs. BBC - Volatility Comparison
The current volatility for Invesco Nasdaq Biotechnology ETF (IBBQ) is 4.42%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 9.22%. This indicates that IBBQ experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.